Paracetamol market penetration rate in different clinical fields (Q2, 2019)


MedAnalytics measures Paracetamol market penetration in different clinical practices. The report is often a source of untapped market potential that might exist in own brand marketing.The market penetration of Paracetamol varied in different clinical practices. last one year period, market penetrations was observed 20% in general physicians, 18% in oncologists, 18% in pediatric surgeons, 18% in internal medicine specialists, 17% in hepatobiliary surgeons, 17% in diabetologists, 16% in orofacial & maxillary surgeons, 16% in nephrologists, 16% in endocrinologists, 16% in ent specialists, 16% in gynecologists & obstetricians, 15% in neurosurgeons, 15% in orthopaedic surgeons, 15% in rheumatology specialists, 15% in physical medicine specialists, 15% in cardiologists, 15% in dentists, 14% in hepatologists, 14% in plastic surgeons, 14% in urologists, 14% in neurologists, 14% in gastroenterologists, 14% in ophthalmologists, 14% in critical care medicine specialists, 14% in cardio-vascular surgeons, 14% in respiratory medicine specialists, 14% in general & laparoscopic surgeons, 14% in pediatricians, 13% in psychiatrists, 13% in hematologists, 13% in cancer surgeons, 13% in dermatologists, 13% in anesthesia & icu specialists, 10% in infertility specialists and 10% in colorectal surgeons.For example, market penetration rate of a generic found 10% in dermatology practice. It means, 10% dermatology practitioners are potential to prescribe this generic. This kind of report is often a source for discovering an untapped market potential that may exist around in marketing own brand.

You might be interested to our other reports

Get Registered for more details